BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15837323)

  • 1. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
    Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
    Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2003 Dec; 46(25):5471-7. PubMed ID: 14640555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.
    Ilies MA; Vullo D; Pastorek J; Scozzafava A; Ilies M; Caproiu MT; Pastorekova S; Supuran CT
    J Med Chem; 2003 May; 46(11):2187-96. PubMed ID: 12747790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
    Abbate F; Casini A; Owa T; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jan; 14(1):217-23. PubMed ID: 14684331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
    Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII.
    Seršen S; Traven K; Kljun J; Turel I; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):388-393. PubMed ID: 30734595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibition effects.
    Bülbül M; Saraçoğlu N; Küfrevioğlu OI; Ciftçi M
    Bioorg Med Chem; 2002 Aug; 10(8):2561-7. PubMed ID: 12057645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: ureido and thioureido derivatives of aromatic sulfonamides possessing increased affinities for isozyme I. A novel route to 2,5-disubstituted-1,3,4-thiadiazoles via thioureas, and their interaction with isozymes I, II and IV.
    Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Apr; 13(2):103-23. PubMed ID: 9629531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.
    Angeli A; Chiaramonte N; Manetti D; Romanelli MN; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):303-308. PubMed ID: 29280407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
    Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
    J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureidobenzenesulfonamides as Selective Carbonic Anhydrase I, IX, and XII Inhibitors.
    Denner TC; Angeli A; Ferraroni M; Supuran CT; Csuk R
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes.
    Supuran CT; Scozzafava A; Ilies MA; Briganti F
    J Enzyme Inhib; 2000; 15(4):381-401. PubMed ID: 10995069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates.
    El-Gazzar MG; Nafie NH; Nocentini A; Ghorab MM; Heiba HI; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1565-1574. PubMed ID: 30274535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.
    Romagnoli R; De Ventura T; Manfredini S; Baldini E; Supuran CT; Nocentini A; Brancale A; Bortolozzi R; Manfreda L; Viola G
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270180. PubMed ID: 37850364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII.
    Mikulová MB; Kružlicová D; Pecher D; Petreni A; Supuran CT; Mikuš P
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide-hydantoin hybrids.
    Abdoli M; Bonardi A; Gratteri P; Supuran CT; Žalubovskis R
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2335927. PubMed ID: 38606915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes.
    Supuran CT; Scozzafava A; Saramet I; Banciu MD
    J Enzyme Inhib; 1998 Jun; 13(3):177-94. PubMed ID: 9629536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.